Prevalence and patterns of anti‐nuclear antibodies in Korean children with juvenile idiopathic arthritis according to ILAR criteria

References

• Ravelli A., Martini A. Juvenile idiopathic arthritis. Lancet 2007; 369: 767–78
   PubMed Web of Science ®Google Scholar
• Levalampi T., Honkanen V., Lahdenne P., Nieminen R., Hakala M., Moilanen E. Effects of infliximab on cytokines, myeloperoxidase, and soluble adhesion molecules in patients with juvenile idiopathic arthritis. Scand J Rheumatol 2007; 36: 189–93
   PubMed Web of Science ®Google Scholar
• Nguyen T. T., Gehrmann M., Zlacka D., Sosna A., Vavrincova P., Multhoff G., et al. Heat shock protein 70 membrane expression on fibroblast‐like synovial cells derived from synovial tissue of patients with rheumatoid and juvenile idiopathic arthritis. Scand J Rheumatol 2006; 35: 447–53
   PubMed Web of Science ®Google Scholar
• Brewer E. J Jr., Bass J., Baum J., Cassidy J. T., Fink C., Jacobs J., et al. Current proposed revision of JRA criteria. JRA Criteria Subcommittee of the Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Section of The Arthritis Foundation. Arthritis Rheum 1977; 20((2 Suppl))195–9
   PubMedGoogle Scholar
• Wood P. H. Special meeting on nomenclature and classification of arthritis in children. EULAR Publishers, Basel 1978; 47–50
   Google Scholar
• Petty R. E., Southwood T. R., Baum J., Bhettay E., Glass D. N., Manners P., et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol 1998; 25: 1991–4
   PubMedGoogle Scholar
• Leak A. M., Ansell B. M., Burman S. J. Antinuclear antibody studies in juvenile chronic arthritis. Arch Dis Child 1986; 61: 168–72
   PubMed Web of Science ®Google Scholar
• Szer W., Sierakowska H., Szer I. S. Antinuclear antibody profile in juvenile rheumatoid arthritis. J Rheumatol 1991; 18: 401–8
   PubMedGoogle Scholar
• Wallace C. A., Ruperto N., Giannini E., Childhood Arthritis and Rheumatology Research Alliance Pediatric Rheumatology International Trials Organization Pediatric Rheumatology Collaborative Study Group. Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheumatol 2004; 31: 2290–4
   PubMed Web of Science ®Google Scholar
• Borchers A. T., Selmi C., Cheema G., Keen C. L., Shoenfeld Y., Gershwin M. E. Juvenile idiopathic arthritis. Autoimmun Rev 2006; 5: 279–98
   PubMed Web of Science ®Google Scholar
• Berntson L., Andersson Gare B., Fasth A., Herlin T., Kristinsson J., Lahdenne P., , Nordic Study Group, et al. Incidence of juvenile idiopathic arthritis in the Nordic countries. A population based study with special reference to the validity of the ILAR and EULAR criteria. J Rheumatol 2003; 30: 2275–82
   PubMed Web of Science ®Google Scholar
• Pruunsild C., Uibo K., Liivamägi H., Tarraste S., Talvik T., Pelkonen P. Incidence of juvenile idiopathic arthritis in children in Estonia: a prospective population‐based study. Scand J Rheumatol 2007; 36: 7–13
   PubMed Web of Science ®Google Scholar
• Danner S., Sordet C., Terzic J., Donato L., Velten M., Fischbach M., et al. Epidemiology of juvenile idiopathic arthritis in Alsace, France. J Rheumatol 2006; 33: 1377–81
   PubMed Web of Science ®Google Scholar
• Thomson W., Barrett J. H., Donn R., Pepper L., Kennedy L. J., Ollier W. E., , British Paediatric Rheumatology Study Group, et al. Juvenile idiopathic arthritis classified by the ILAR criteria: HLA associations in UK patients. Rheumatology 2002; 41: 1183–9
   PubMed Web of Science ®Google Scholar
• Kasapçopur O., Yologlu N., Ozyazgan Y., Ercan G., Caliskan S., Sever L., et al. Uveitis and anti nuclear antibody positivity in children with juvenile idiopathic arthritis. Indian Pediatr 2004; 41: 1035–9
   PubMedGoogle Scholar
• Ruperto N., Ravelli A., Levinson J. E., Shear E. S., Murray K., Link Tague B., et al. Long‐term health outcomes and quality of life in American and Italian inception cohorts of patients with juvenile rheumatoid arthritis. II. Early predictors of outcome. J Rheumatol 1997; 24: 952–8
   PubMedGoogle Scholar
• Oen K., Malleson P. N., Cabral D. A., Rosenberg A. M., Petty R. E., Reed M., et al. Early predictors of longterm outcome in patients with juvenile rheumatoid arthritis: subset‐specific correlations. J Rheumatol 2003; 30: 585–93
   PubMedGoogle Scholar
• Ravelli A., Felici E., Magni‐Manzoni S., Pistorio A., Novarini C., Bozzola E., et al. Patients with antinuclear antibody‐positive juvenile idiopathic arthritis constitute a homogeneous subgroup irrespective of the course of joint disease. Arthritis Rheum 2005; 52: 826–32
   PubMed Web of Science ®Google Scholar
• Felici E., Novarini C., Magni‐Manzoni S., Pistorio A., Magnani A., Bozzola E., et al. Course of joint disease in patients with antinuclear antibody‐positive juvenile idiopathic arthritis. J Rheumatol 2005; 32: 1805–10
   PubMed Web of Science ®Google Scholar
• Wananukul S., Voramethkul W., Kaewopas Y., Hanvivatvong O. Prevalence of positive antinuclear antibodies in healthy children. Asian Pac J Allergy Immunol 2005; 23: 153–7
   PubMed Web of Science ®Google Scholar
• Park P. W., Kim T. Y. Antinuclear antibodies in patients on medication with anticonvulsants. J Korean Rheum Assoc 2002; 9: 298–303
   Google Scholar
• Shin J. I., Park J. M., Lee J. S., Kim M. J. Effect of renal Doppler ultrasound on the detection of nutcracker syndrome in children with hematuria. Eur J Pediatr 2007; 166: 399–404
   PubMed Web of Science ®Google Scholar
• Mohan T. C., Nadarajah M., Sng E. H. Relation of antinuclear fluorescence patterns and titres to autoantibody prevalence. Ann Acad Med Singapore 1989; 18: 339–44
   PubMedGoogle Scholar
• Dreher R. Heterogeneity of antinuclear antibodies (ANA), immunoglobulin‐ and complement levels in sera of patients with rheumatoid arthritis (RA). Immun Infekt 1977; 5: 11–22
   PubMedGoogle Scholar